Literature DB >> 10480607

Expression of alpha-1 proteinase inhibitor in human islet microvascular endothelial cells.

J Lou1, F Triponez, J Oberholzer, H Wang, D Yu, L Buhler, N Cretin, G Mentha, C B Wollheim, P Morel.   

Abstract

There is a microcirculation system within the islets of Langerhans. However, little is known about the phenotypic and functional characterization of islet microvascular endothelial cells (MVEC). In this study, we purified MVEC from human pancreatic islets by using Ulex europaeus (Sigma, St. Louis, MO) agglutinin-1 (UEA-1)-coated dynabeads (Dynal A.S., Oslo, Norway). These purified human islet MVEC (HI-MVEC) express von Willebrand factor, take up high levels of acetylated LDL, and upregulate endothelial cell leukocyte adhesion molecule 1 in response to tumor necrosis factor-alpha. Ultrastructure examination shows the presence of microvilli and fenestrations on the cell surface, Weibel-Palade bodies in the cytoplasm, and tight junctions between cells. Furthermore, we show that vascular endothelial cell growth factor contributes to the formation of surface fenestrations on cultured HI-MVEC. After purification, HI-MVEC exhibit a very low proliferation capacity and are strongly resistant to trypsin, compared with other original MVEC. We also demonstrate that alpha-1 proteinase inhibitor (Api) is expressed on HI-MVEC and specifically located at the area of cell-cell junctions. By reverse transcription-polymerase chain reaction, a significant messenger RNA band of Api was found only in HI-MVEC, but not in other organ-derived MVEC, indicating that expression of Api is islet MVEC specific. Antibodies to Api significantly reversed the resistance to trypsin and promoted proliferation of HI-MVEC, suggesting that these specific functional characteristics of HI-MVEC are related to the expression of Api. These results indicate that HI-MVEC exhibit some specific morphological and functional characteristics that differ from MVEC derived from other organs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480607     DOI: 10.2337/diabetes.48.9.1773

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Perinatal development of the pancreatic islet microvasculature in rats.

Authors:  Magnus Johansson; Arne Andersson; Per-Ola Carlsson; Leif Jansson
Journal:  J Anat       Date:  2006-02       Impact factor: 2.610

Review 2.  Islet vasculature as a regulator of endocrine pancreas function.

Authors:  Nikiforos Ballian; F Charles Brunicardi
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

3.  Primary and immortalised human pancreatic islet endothelial cells: phenotypic and immunological characterisation.

Authors:  E Favaro; A Bottelli; B Lozanoska-Ochser; E Ferioli; G C Huang; N Klein; A Chiaravalli; P Cavallo Perin; G Camussi; M Peakman; P G Conaldi; M M Zanone
Journal:  Diabetologia       Date:  2005-11-15       Impact factor: 10.122

Review 4.  Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?

Authors:  Diana Crossley; Robert Stockley; Elizabeth Sapey
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

Review 5.  Endothelium-derived essential signals involved in pancreas organogenesis.

Authors:  Dodanim Talavera-Adame; Donald C Dafoe
Journal:  World J Exp Med       Date:  2015-05-20

Review 6.  The Role of Accessory Cells in Islet Homeostasis.

Authors:  Shiue-Cheng Tang; Claire F Jessup; Martha Campbell-Thompson
Journal:  Curr Diab Rep       Date:  2018-09-28       Impact factor: 4.810

7.  Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells.

Authors:  Domenico Bosco; Paolo Meda; Philippe Morel; David Matthey-Doret; Dorothée Caille; Christian Toso; Leo H Bühler; Thierry Berney
Journal:  Diabetologia       Date:  2005-07-07       Impact factor: 10.122

8.  Expression of nephrin by human pancreatic islet endothelial cells.

Authors:  M M Zanone; E Favaro; S Doublier; B Lozanoska-Ochser; M C Deregibus; J Greening; G C Huang; N Klein; P Cavallo Perin; M Peakman; G Camussi
Journal:  Diabetologia       Date:  2005-07-12       Impact factor: 10.122

Review 9.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

10.  Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets.

Authors:  Johan Olerud; Magnus Johansson; Jack Lawler; Nils Welsh; Per-Ola Carlsson
Journal:  Diabetes       Date:  2008-04-16       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.